PBYI
PBYI
NASDAQ · Biotechnology

Puma Biotechnology Inc

$8.91
+0.79 (+9.73%)
As of Aug 8, 10:25 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -38.8% upside
Low Target $2.99
Average Target $5.45
High Target $6.80
Current Price $8.91
Current
$8.91
Target
$5.45
$2.99 $5.45 avg $6.80
Scenario Analysis
Bear Case
$2.99
-66.4%
Low target
Base Case
$5.45
-38.8%
Avg target
Bull Case
$6.80
+-23.7%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$8.75
1.8% from high
52-Week Low
$3.05
+192.1% from low
Target vs 52W High
$5.45
-37.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%